Answers are grounded in this paper and cite their sources.
A new synthesis of sumanirole that is being developed to treat Parkinson's disease is described. The basic skeleton is constructed from 8-hydroxyquinoline and elaborated to the key tricylic intermediate 14. Further elaboration affords a 1,2-amino alcohol, which is converted to an aziridine by a new process. Finally, dissolving metal reduction to open the aziridine and protecting group removal affords sumanirole.
No takes yet. Share an insight, caveat, or question.
Wuts et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: